Hutchmed earnings were $37.7M for the trailing 12 months ending Dec 31, 2024, with -66.7% growth year over year. The latest HCM earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HCM reported annual earnings of $37.7M, with -62.6% growth.
HCM past earnings growth
How has HCM's earnings growth performed historically?
On HCM's earnings call on Invalid Date, Hutchmed (NASDAQ: HCM) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total HCM earnings for the quarter were N/A. In the same quarter last year, Hutchmed's earnings per share (EPS) was N/A.
As of the last Hutchmed earnings report, Hutchmed is currently profitable. Hutchmed's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $37.73 million, a 62.56% decrease year over year.
What was HCM's earnings growth in the past year?
As of Hutchmed's earnings date in Invalid Date, Hutchmed's earnings has grown -66.67% year over year. This is 67.93 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 1.26%. HCM earnings in the past year totalled $37.73 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.